Drugs / Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant
Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00853255 | Jul 2010 → Aug 2011 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00853255 ↗ |
| Modality | Vaccine | “live, attenuated AI virus vaccine” NCT00853255 ↗ |
| Route | Intranasal | “Vaccine administered by nasal spray” NCT00853255 ↗ |